Rene Van Melick
The FDA’s QMM program promises a radical shake-up of how pharmaceutical quality is perceived, measured and rewarded.
CPDS proces QM methods will bring you to the high maturity level.
Learn how to align with the program and use it to your advantage!
‘ Introduction FDA’s Center for Drug Evaluation and Research (CDER) is establishing a program to promote quality management maturity (QMM) at drug manufacturing establishments. CDER is developing its QMM Assessment Tool (protocol and rubric) to evaluate how effectively establishments monitor and manage quality and quality systems. The QMM program aims to encourage drug manufacturers to implement quality management practices that go beyond current good manufacturing practice (CGMP)requirements.1 The goals of this program are fourfold: 1. Foster a strong quality culture mindset 2. Recognize establishments that have advanced quality management practices and acknowledge establishments that strive to continually improve quality management practices 3. Identify areas where quality management practices can be enhanced and provide suggestions for growth opportunities 4. Minimize risks to product availability to assure reliable market supply Adopting mature quality management practices supports a more reliable drug supply chain by reducing the occurrence of quality-related failures and improving the ability of establishments to maintain performance during expected and unexpected supply chain disruptions. Integrating business and manufacturing operations with quality practices and technological advancements can help achieve higher levels of maturity. This can optimize manufacturing process performance and product quality, enhance supply chain reliability, and foster proactive continual improvement. The next critical step in implementing this program is developing the protocol that assesses the QMM of manufacturing establishments. This prototype assessment protocol will be tested and refined during the 2024 calendar year”
FDA’s Center for Drug Evaluation and Research (CDER) is establishing a program to promote quality management maturity (QMM) at drug manufacturing establishments.
Read and participate to develop.